Erica Schwartz’s CDC Nomination Hearing Highlights Vaccine Policy Tensions

President Donald Trump’s nominee for director of the U.S. Centers for Disease Control and Prevention, Dr. Erica Schwartz, testified before the Senate Health, Education, Labor and Pensions Committee. She affirmed confidence in vaccines, including mRNA COVID‑19 shots, and pledged to “follow the science wherever it leads” while promising radical transparency to rebuild public trust.

Lawmakers focused on her ability to remain independent from Health and Human Services Secretary Robert F. Kennedy Jr., whose anti‑vaccine stance has drawn criticism. Senators asked whether she would resist directives that conflicted with scientific evidence; Schwartz declined to give hypothetical answers and did not directly criticize Kennedy’s policies. Her military medical background was highlighted as experience that could help restore credibility to the agency.

The hearing underscored ongoing concerns that political influence could shape CDC vaccine guidance and highlighted the administration’s effort to reassert control over public‑health messaging.